ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.67
0.00%
US Tech 100
19,131.60
-0.23%
S&P 500
5,477.90
0.16%
US Dollar vs CAD
1.36901
-0.11%
Bitcoin
60,646.49
-0.27%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Black Diamond Therapeutics Inc (BDTX)

  7. Black Diamond Therapeutics Inc (BDTX) News

BDTX

Black Diamond Therapeutics (BDTX)

Black Diamond Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BDTX
DateTimeSourceHeadlineSymbolCompany
06/06/20244:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
06/06/20244:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
06/06/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
06/01/20249:00AMGlobeNewswire Inc.Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
05/29/20247:00AMGlobeNewswire Inc.Black Diamond Therapeutics to Participate in Jefferies Global Healthcare ConferenceNASDAQ:BDTXBlack Diamond Therapeutics Inc
05/13/20246:09PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BDTXBlack Diamond Therapeutics Inc
05/09/20246:30AMGlobeNewswire Inc.Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
05/09/20246:13AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDTXBlack Diamond Therapeutics Inc
05/09/20246:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
04/24/20243:05PMGlobeNewswire Inc.Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
04/11/20247:00AMGlobeNewswire Inc.Black Diamond Therapeutics Announces Changes to Board of DirectorsNASDAQ:BDTXBlack Diamond Therapeutics Inc
04/07/20245:00PMGlobeNewswire Inc.Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
04/03/20247:00AMGlobeNewswire Inc.Black Diamond Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BDTXBlack Diamond Therapeutics Inc
03/12/20247:00AMGlobeNewswire Inc.Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
03/11/202412:14PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BDTXBlack Diamond Therapeutics Inc
03/05/20243:30PMGlobeNewswire Inc.Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024NASDAQ:BDTXBlack Diamond Therapeutics Inc
02/28/20247:00AMGlobeNewswire Inc.Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:BDTXBlack Diamond Therapeutics Inc
02/15/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
02/15/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
02/15/20244:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
02/15/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
02/14/20249:04AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BDTXBlack Diamond Therapeutics Inc
01/18/20243:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
01/04/20247:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
01/04/20247:00AMGlobeNewswire Inc.Black Diamond Therapeutics Announces Corporate Update and Expected 2024 MilestonesNASDAQ:BDTXBlack Diamond Therapeutics Inc
12/13/20236:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
12/13/20236:00AMGlobeNewswire Inc.Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBMNASDAQ:BDTXBlack Diamond Therapeutics Inc
11/07/20237:00AMGlobeNewswire Inc.Black Diamond Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BDTXBlack Diamond Therapeutics Inc
11/06/20236:45AMGlobeNewswire Inc.Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
11/06/20236:14AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDTXBlack Diamond Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BDTX

Your Recent History

USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
DPUI
Discount Print USA (PK)
USOTC
GNCP
GNCC Capital (CE)
USOTC
CYDY
CytoDyn (QB)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
TSLA
Tesla
USOTC
UEEC
United Health Products (PK)
NASDAQ
RVNC
Revance Therapeutics
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
ECSL
Ecare Solutions (PK)
NASDAQ
AMRN
Amarin
USOTC
SAPX
Seven Arts Entertainment (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
RDGL
Vivos (QB)
USOTC
AFFU
Affluence (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved